A carregar...
Regional Variation in Use of a New Class of Antidiabetic Medication Among Medicare Beneficiaries: The Case of Incretin Mimetics
BACKGROUND: When incretin mimetic (IM) medications were introduced in 2005, their effectiveness compared other less-expensive second-line diabetes therapies was unknown, especially for older adults. Physicians likely had uncertainty about the role of IMs in the diabetes treatment armamentarium. Regi...
Na minha lista:
Publicado no: | Ann Pharmacother |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876962/ https://ncbi.nlm.nih.gov/pubmed/25515869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1060028014563951 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|